about
Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritisSolution-phase synthesis of a diverse isocoumarin libraryCharacterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties.Mechanisms relevant to the enhanced virulence of a dihydroxynaphthalene-melanin metabolically engineered entomopathogenX-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase.Catalyst-Free Synthesis of Borylated Lactones from Esters via Electrophilic Oxyboration.Extracts of Renealmia alpinia (Rottb.) MAAS Protect against Lethality and Systemic Hemorrhage Induced by Bothrops asper Venom: Insights from a Model with Extract Administration before Venom InjectionOne-step multiple component isolation from the oil of Crinitaria tatarica (Less.) Sojak by preparative capillary gas chromatography with characterization by spectroscopic and spectrometric techniques and evaluation of biological activity.Benzopyrone coumarin leads to an inhibition of ochratoxin biosynthesis in representatives of Aspergillus and Penicillium spp. via a type of feedback response mechanism.Effects of selected South African plant extracts on haemolysis and coagulation.3D-quantitative structure-activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors.Regioselective synthesis of 3,4-disubstituted isocoumarins through the Pd-catalyzed annulation of 2-iodoaromatic acids with ynamides.
P2860
Q28589300-59223B47-CD80-46B5-A4B1-90B9DCF6952BQ33509589-BE86AD24-6B1E-4AD2-A8EC-8A85DEFC776DQ35128179-790873B4-0A72-4E16-9E3A-12E04DC84E17Q35129103-F0EFCE27-DD15-495B-A9DC-4E9E000D5C72Q36516884-E328DE6B-DFA1-4EEA-9B11-BA1A7A5CB6CAQ37890978-84D43CC0-C7F1-4811-ACCB-EB9C301F325FQ38647474-1F80758D-0277-4B4B-9DF8-3EF918136574Q41318584-E113B731-3838-472D-8059-7E76712E3C36Q42977721-A2BA3C0F-E870-4BC2-960B-A6D6E6C0A9E3Q44096499-737C1237-D2EE-4F08-8B5D-849F550FA6D5Q47323571-216362C7-F31A-44AB-85F5-8FD9B7FD427EQ48099437-DF2B2FAE-3D2D-4DB8-8F95-2972FF9FCD81Q51353328-7B5B08A6-F330-4E4C-B243-EEE547842C1A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Coumarin and isocoumarin as serine protease inhibitors.
@ast
Coumarin and isocoumarin as serine protease inhibitors.
@en
type
label
Coumarin and isocoumarin as serine protease inhibitors.
@ast
Coumarin and isocoumarin as serine protease inhibitors.
@en
prefLabel
Coumarin and isocoumarin as serine protease inhibitors.
@ast
Coumarin and isocoumarin as serine protease inhibitors.
@en
P356
P1476
Coumarin and isocoumarin as serine protease inhibitors
@en
P2093
Bernard Masereel
P304
P356
10.2174/1381612043382684
P577
2004-01-01T00:00:00Z